iEV injections for chronic tennis elbow (lateral epicondylitis)
Official title: A Clinical Trial Study Evaluating the Safety and Preliminary Efficacy of Human Induced Pluripotent Stem Cell-derived Extracellular Vesicles (iEVs) Injection for the Treatment of Lateral Epicondylitis of the Humerus
Run by Shanghai 6th People's Hospital · NCT07111325 · Data updated 2026-11-12
This trial will see if injections of extracellular vesicles made from human induced pluripotent stem cells (iEVs) can help people with chronic tennis elbow reduce pain and improve elbow function.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Shanghai 6th People's Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | July 1, 2023 |
| Main results expected | December 1, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | August 8, 2025 |
| Trial ID | NCT07111325 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with unilateral lateral epicondylitis lasting at least 12 weeks, confirmed by MRI or ultrasound, with pain VAS >3 who have not responded to physical therapy or NSAIDs and who can provide informed consent are ideal candidates.
✕Probably not a fit
Patients with ipsilateral neurogenic, inflammatory, or systemic joint disease, obvious tendon tear, recent lateral epicondylitis surgery (within 6 months), or other non-tendinopathic causes of elbow pain are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, phase 1/2 randomized controlled study will test the safety and preliminary efficacy of human iPSC-derived extracellular vesicle (iEV) injections for lateral epicondylitis. Participants will be block-randomized without stratification to one of three arms: iEV injection (experimental), platelet-rich plasma (positive control), or immobilization (negative control). The study plans small cohorts (approximately 6–12 in the experimental arm and 3–6 in each control arm) and will follow patients for changes in pain, grip strength, elbow function, and markers of tendon inflammatory status using clinical exams and imaging. Safety endpoints and adverse events will be closely monitored given the early-phase nature of the intervention.
Why it matters
Potential benefit: If successful, the iEV injections could reduce pain, improve grip strength and elbow function, and help resolve tendon inflammation more quickly than conservative care.
How similar studies have gone: PRP has produced mixed results in prior tennis elbow studies, and iEV injections are a novel biologic approach with very limited published human data to date.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with lateral epicondylitis by clinical symptom examination and MRI or ultrasound, without obvious tendon tear; * Unilateral lateral elbow pain lasting for more than 12 weeks; * Pain is provoked by at least 2 of the following methods, with a pain VAS score exceeding 3: maximum grip strength, palpation of the lateral epicondyle of the elbow and surrounding area, resisted dorsiflexion of the wrist or middle finger, or stretching of the forearm extensor muscles under a pain-free grip state; * Having received physical therapy or non-steroidal anti-inflammatory drug treatment with poor efficacy; * Individuals with independent behavioral capacity, who have signed the informed consent form themselves. Exclusion Criteria: * Complaints of ipsilateral muscle pain caused by other reasons in the past 6 months; * Presence of ipsilateral neurogenic, inflammatory, or systemic joint diseases; * A history of previous lateral epicondylitis (LET) surgery in the past 6 months; * Subjects deemed unsuitable for participating in the trial due to other conditions, as judged by the researcher; * MRI showing that the injury has involved the lateral collateral ligament, with concurrent cartilage damage.
Where it's running
-
Shanghai Sixth hospital
Shanghai, Shanghai Municipality, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-guided nerve block and injections for elbow pain in lateral epicondylitis
This study tests whether an ultrasound-guided posterior cutaneous nerve of the forearm epicondylar branch block, with or without a triamcinolone injection, can reduce pain and improve elbow function in adults with lateral epicondylitis.
-
Central Sensitization and Ultrasound in Lateral Epicondylitis
This study tests whether people with chronic tennis elbow have different pressure pain thresholds and ultrasound findings compared with healthy controls.
-
Combining ESWT and Blood Flow Restriction Therapy for Lateral Epicondylitis
This study tests whether combining extracorporeal shock wave therapy (ESWT) with blood flow restriction (BFR) therapy helps people with lateral epicondylitis restore function and reduce pain.
-
Effectiveness of TECAR therapy with exercise for lateral epicondylitis
This randomized trial tests whether adding TECAR therapy to a standard exercise program helps reduce pain and improve function in people with tennis elbow.
-
Heavy slow-resistance wrist exercises and shoulder stabilization to reduce pain and improve grip in tennis elbow
This test will compare six weeks of heavy slow-resistance wrist exercises against shoulder stabilization exercises to see which better reduces pain and improves grip and function in adults aged 30–50 with tennis elbow.
-
Eccentric Exercises With Muscle Energy Technique for Lateral Epicondylitis
This trial tests whether combining eccentric exercises with muscle energy technique helps reduce pain and improve function for people with tennis elbow.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.